Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Midtreatment evaluation of lymphoma response to chemotherapy by volume perfusion computed tomography.

Spira D, Grünwald L, Vogel W, Sauter A, Spira SM, Claussen CD, Horger M.

J Comput Assist Tomogr. 2014 Jan-Feb;38(1):123-30. doi: 10.1097/RCT.0b013e3182a90ee7.

PMID:
24378894
2.

Assessment of the nature of residual masses at end of treatment in lymphoma patients using volume perfusion computed tomography.

Syha R, Grünwald L, Horger T, Spira D, Ketelsen D, Vogel W, Claussen CD, Horger M.

Eur Radiol. 2014 Mar;24(3):770-9. doi: 10.1007/s00330-013-3077-6. Epub 2013 Dec 5.

PMID:
24306426
3.

Perfusion and flow extraction product as potential discriminators in untreated follicular and diffuse large B cell lymphomas using volume perfusion CT with attempt at histopathologic explanation.

Spira D, Adam P, Linder C, Spira SM, Pintoffl J, Claussen CD, Horger M.

AJR Am J Roentgenol. 2012 Jun;198(6):1239-46. doi: 10.2214/AJR.11.7858.

PMID:
22623535
4.
5.

Assessment of tumor vascularity in lung cancer using volume perfusion CT (VPCT) with histopathologic comparison: a further step toward an individualized tumor characterization.

Spira D, Neumeister H, Spira SM, Hetzel J, Spengler W, von Weyhern CH, Horger M.

J Comput Assist Tomogr. 2013 Jan-Feb;37(1):15-21. doi: 10.1097/RCT.0b013e318277c84f.

PMID:
23321828
6.

Reproducibility of VPCT parameters in the normal pancreas: comparison of two different kinetic calculation models.

Kaufmann S, Schulze M, Horger T, Oelker A, Nikolaou K, Horger M.

Acad Radiol. 2015 Sep;22(9):1099-105. doi: 10.1016/j.acra.2015.04.005. Epub 2015 Jun 23.

PMID:
26112056
7.

Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.

Thaiss WM, Haberland U, Kaufmann S, Spira D, Thomas C, Nikolaou K, Horger M, Sauter AW.

Eur Radiol. 2016 Sep;26(9):2929-36. doi: 10.1007/s00330-015-4154-9. Epub 2015 Dec 17.

PMID:
26679179
8.

Effect of scan time on perfusion and flow extraction product (K-trans) measurements in lung cancer using low-dose volume perfusion CT (VPCT).

Spira D, Gerlach JD, Spira SM, Schulze M, Sauter A, Horger M.

Acad Radiol. 2012 Jan;19(1):78-83. doi: 10.1016/j.acra.2011.09.010. Epub 2011 Nov 3.

PMID:
22054806
9.

Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume.

Petralia G, Preda L, Giugliano G, Jereczek-Fossa BA, Rocca A, D'Andrea G, Holalkere NS, Chiesa F, Bellomi M.

J Comput Assist Tomogr. 2009 Jul-Aug;33(4):552-9. doi: 10.1097/RCT.0b013e31818d446e.

PMID:
19638848
10.

Low-dose volume perfusion computed tomography (VPCT) for diagnosis of solitary pulmonary nodules.

Sun Y, Yang M, Mao D, Lv F, Yin Y, Li M, Hua Y.

Eur J Radiol. 2016 Jun;85(6):1208-18. doi: 10.1016/j.ejrad.2016.03.026. Epub 2016 Mar 30.

PMID:
27161072
11.

Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.

Kaufmann S, Horger T, Oelker A, Kloth C, Nikolaou K, Schulze M, Horger M.

Eur J Radiol. 2015 Jun;84(6):1029-35. doi: 10.1016/j.ejrad.2015.02.020. Epub 2015 Mar 6.

PMID:
25816994
12.

Assessment of splenic perfusion in patients with malignant hematologic diseases and spleen involvement, liver cirrhosis and controls using volume perfusion CT (VPCT): a pilot study.

Sauter AW, Feldmann S, Spira D, Schulze M, Klotz E, Vogel W, Claussen CD, Horger MS.

Acad Radiol. 2012 May;19(5):579-87. doi: 10.1016/j.acra.2012.01.007. Epub 2012 Feb 9.

PMID:
22326669
13.

Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.

Reiner CS, Roessle M, Thiesler T, Eberli D, Klotz E, Frauenfelder T, Sulser T, Moch H, Alkadhi H.

Invest Radiol. 2013 Apr;48(4):183-91. doi: 10.1097/RLI.0b013e31827c63a3.

PMID:
23328912
15.

Does volume perfusion computed tomography enable differentiation of metastatic and non-metastatic mediastinal lymph nodes in lung cancer patients? A feasibility study.

Spira D, Wecker M, Spira SM, Hetzel J, Spengler W, Sauter A, Horger M.

Cancer Imaging. 2013 Jul 22;13(3):323-31. doi: 10.1102/1470-7330.2013.0033.

16.

Explanations for the heterogeneity of splenic enhancement derived from blood flow kinetic measurements using dynamic contrast-enhanced CT (DCE-CT).

Sauter AW, Spira D, Schulze M, Horger MS.

Acta Radiol. 2014 Jul;55(6):645-53. doi: 10.1177/0284185113503322. Epub 2013 Sep 4.

PMID:
24005563
17.

Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements.

Bisdas S, Rumboldt Z, Wagenblast J, Baghi M, Koh TS, Hambek M, Vogl TJ, Mack MG.

AJNR Am J Neuroradiol. 2009 Apr;30(4):793-9. doi: 10.3174/ajnr.A1449.

18.

Reduced perfusion in pulmonary infiltrates of high-risk hematologic patients is a possible discriminator of pulmonary angioinvasive mycosis: a pilot volume perfusion computed tomography (VPCT) study.

Schulze M, Vogel W, Spira D, Sauter A, Hetzel J, Horger M.

Acad Radiol. 2012 Jul;19(7):842-50. doi: 10.1016/j.acra.2012.03.002. Epub 2012 Apr 11.

PMID:
22498759
19.

[Feasibility of volume perfusion CT (VPCT) imaging in antiangiogenic treatment of rabbit VX2 soft-tissue tumor].

Yang P, Feng XW, Ye ZX, Li XB, Hou Y, Liu YT, Xiao JY.

Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):341-6. doi: 10.3760/cma.j.issn.0253-3766.2013.05.005. Chinese.

PMID:
24054009
20.

Dynamic volume perfusion computed tomography parameters versus RECIST for the prediction of outcome in lung cancer patients treated with conventional chemotherapy.

Sudarski S, Shi J, Schmid-Bindert G, Manegold C, Pilz LR, Zhou C, Schoenberg SO, Henzler T.

J Thorac Oncol. 2015 Jan;10(1):164-71. doi: 10.1097/JTO.0000000000000376.

Supplemental Content

Support Center